close

Enter

Log in using OpenID

Pemphigus Vulgaris Treatment Market

embed
Pemphigus Vulgaris Treatment Market - Size,
Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Pemphigus vulgaris is an autoimmune disorder in which painful blisters are formed on the mucus
membrane and skin. The disorder is rare and affects mouth, nose, throat, lungs, eyes, and
sometimes genitals. The disorder is caused when the body produces antibodies against self-cells,
although the exact cause and mechanism is unknown. Formation of Immunoglobulin G (IgG)
antibodies against self desmosomal adhesion proteins, present on epidermal keratinocytes, results in
blister formation. Its diagnosis involves biopsy (tissue sampling), blood tests for pemphigus specific
antibodies, and endoscopy. The treatment involves administration of immunosuppressant drugs and
corticosteroids.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2530
Pemphigus Vulgaris Treatment Market Drivers
New drug approvals is expected to drive the global pemphigus vulgaris treatment market growth
over the forecast period. For instance, in June 2018, the U.S. Food and Drug Administration (FDA)
approved the use of Rituximab for the treatment of pemphigus vulgaris. Rituximab is a
humanized anti-cd20 monoclonal antibody and acts to reduce the number of skin lesions. The
drug acts by targeting cd20 antigen, expressed on cells of B cell lineage and kills B cells.
Rituximab acts by inhibiting cell proliferation and inducing cell apoptosis. Rituximab has minimal
immunogenicity and can be reused.
Pemphigus Vulgaris Treatment Market Regional Analysis
Government agencies are indulged in research and development of new drugs for pemphigus
vulgaris treatment. For instance, National Institute of Allergy and Infectious Diseases (NIAID), an
agency of the U.S. Department of Health and Human Services (HHS), is conducting a Phase 1
trial to check use of Polyclonal T regulatory cells in treatment of pemphigus vulgaris. The study
started in September 2017, and is estimated to be completed by September 2020. Therefore,
active research and development by key players in the region is expected to support North
America pemphigus vulgaris treatment market growth over the forecast period.
Report includes chapters which deeply display the following deliverable about industry :
• Pemphigus Vulgaris Treatment Market Research Objective and Assumption
• Pemphigus Vulgaris Treatment Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Pemphigus Vulgaris Treatment Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Pemphigus Vulgaris Treatment Market, By Regions
• Pemphigus Vulgaris Treatment Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Pemphigus Vulgaris Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Pemphigus Vulgaris Treatment Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Pemphigus Vulgaris Treatment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Pemphigus Vulgaris Treatment Market Key Players
Some of the key players operating in the global pemphigus vulgaris treatment market
include, Principia Biopharma, Argenx SE, Alexion Inc., Genentech, Inc., Novartis
International AG, GlaxoSmithKline plc. Vifor Pharma Management Ltd., and F.
Hoffmann-La Roche AG
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2530
Pemphigus Vulgaris Treatment Market Taxonomy
The global pemphigus vulgaris treatment market is segmented on the basis of drugs route of
administration, distribution channel, and region.
By Drugs
Azathioprine
Rituximab
Cyclophosphamide
Cyclosporine
Pipeline drugs
• PRN1008
• Others
•
•
•
•
•
By Route of Administration
• Oral
• Injectable
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
By Region
•
•
•
•
•
•
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Rushikesh
Rushikesh52   documents Email
Document
Category
Health and Medicine
Views
1
File Size
167 KB
Tags
vulgaris
1/--pages
Report inappropriate content